Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AVPR1A | P37288 | 1/20 | 0.44 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.39 |
| ▸ | MMP13 | P45452 | 1/20 | 0.39 |
| ▸ | ACE | P12821 | 1/20 | 0.38 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.37 |
| ▸ | CCR1 | P32246 | 1/20 | 0.37 |
| ▸ | CTSL | P07711 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31294552 | 0.97 | AVPR1A (0.45) | AVPR1AFOLH1MMP13ACE | |
| SCHEMBL31294665 | 0.95 | AVPR1A (0.44) | AVPR1AFOLH1ACE | |
| SCHEMBL31294615 | 0.85 | CPB2 (0.51) | AVPR1ACPB2CTSL | |
| SCHEMBL31294211 | 0.82 | CPB2 (0.48) | AVPR1AFOLH1CPB2CTSL | |
| SCHEMBL31228997 | 0.82 | AVPR1A (0.41) | AVPR1AMMP13 | |
| SCHEMBL31294537 | 0.82 | AVPR1A (0.46) | AVPR1AFOLH1ACECPB2CTSL | |
| SCHEMBL31294428 | 0.81 | FOLH1 (0.44) | AVPR1AFOLH1ACE | |
| SCHEMBL31294381 | 0.81 | FOLH1 (0.44) | AVPR1AFOLH1ACE | |
| SCHEMBL31294293 | 0.81 | FOLH1 (0.44) | AVPR1AFOLH1ACE | |
| SCHEMBL31294556 | 0.80 | FOLH1 (0.43) | AVPR1AFOLH1ACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4702033-A1 | DESMURAMYLPEPTIDE DIACIDS AS NOD2 AGONISTS AND USE THEREOF | Imhotex Limited (GB) | 2026-03-04 | — | — | EP | disclosed |
| WO-2024224086-A1 | DESMURAMYLPEPTIDE DIACIDS AS NOD2 AGONISTS AND USE THEREOF | Imhotex Limited (GB) | 2024-10-31 | — | — | WO | disclosed |